You are here

P&T® Journal contents for August 2008


Inadequately controlled asthma can be very debilitating and costly for patients. The authors emphasize the importance of tracking symptoms, and they recommend a combined strategy in which both patient and claims data are used to ­identify poor asthma control.
Tom James, MD, and Michael Fine, MD
Case Report
A patient with multiple-organ failure recovered from septic shock when a low dose of drotrecogin alfa was administered.
Shan Wang, PharmD, Kristina Dabovic, PharmD, and Ruth S. Spector, MD
Meeting Highlights
Antihypertensive treatments include a dual receptor antagonist (PS433540) and a combination of amlodipine plus olmesartan (Azor).
Reuben B. David
Continuing Education Credit
Part 2 of a two-part series summarizes treatments used to prevent migraine, the most common headache complaint in clinical practice. Current prophylactic ­therapies include selected beta blockers, antidepressants, anticonvulsant agents, NSAIDs, skeletal muscle relaxants, ACE-inhibitors, antipsychotic agents, ­antihistamines, botulinum, and herbal products.
George DeMaagd, PharmD, BCPS


David Nash, MD, MBA, describes the concept of "total leadership" and its value in helping people become more authentic, ­integrated, and ­creative.
David B. Nash, MD, MBA
Medication Errors
In part 1 of a two-part article, Matthew Grissinger, RPh, FASCP, discusses widespread misconceptions about formularies among surveyed health care professionals.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Stephen Barlas discusses the possible passage of a Senate bill that would allow the FDA to approve "near copies" of biotech agents ("biosimilars").
Stephen Barlas
From dronabinol to rosi­glitazone, P&T presents the latest information about FDA approvals, new indications, recalls, and industry updates.
Drug Forecast
The authors review etravirine (Intelence), a second-generation non-nucleoside reverse transcriptase inhibitor, for HIV-1 infection.
Nathaniel Eraikhuemen, PharmD, Angela M. Thornton, PharmD, Evans Branch III, PharmD, Sandrine T. Huynh, PharmD, and Candace Farley, PharmD